Purinergic regulation of the immune system

C Cekic, J Linden - Nature Reviews Immunology, 2016 - nature.com
Cellular stress or apoptosis triggers the release of ATP, ADP and other nucleotides into the
extracellular space. Extracellular nucleotides function as autocrine and paracrine signalling …

Chronic obstructive pulmonary disease: epidemiology, biomarkers, and paving the way to lung cancer

K Szalontai, N Gémes, J Furák, T Varga… - Journal of clinical …, 2021 - mdpi.com
Chronic obstructive pulmonary disease (COPD), the frequently fatal pathology of the
respiratory tract, accounts for half a billion cases globally. COPD manifests via chronic …

Hyaluronan as a therapeutic target in human diseases

J Liang, D Jiang, PW Noble - Advanced Drug Delivery Reviews, 2016 - Elsevier
Accumulation and turnover of extracellular matrix is a hallmark of tissue injury, repair and
remodeling in human diseases. Hyaluronan is a major component of the extracellular matrix …

The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases

L Antonioli, C Blandizzi, P Pacher, G Haskó - Pharmacological reviews, 2019 - ASPET
Immune-mediated inflammatory diseases (IMIDs) encompass a wide range of seemingly
unrelated conditions, such as multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory …

Pathological overproduction: the bad side of adenosine

PA Borea, S Gessi, S Merighi… - British journal of …, 2017 - Wiley Online Library
Adenosine is an endogenous ubiquitous purine nucleoside, which is increased by hypoxia,
ischaemia and tissue damage and mediates a number of physiopathological effects by …

[HTML][HTML] Charting extracellular transcriptomes in the human biofluid RNA atlas

E Hulstaert, A Morlion, FA Cobos, K Verniers… - Cell Reports, 2020 - cell.com
Extracellular RNAs present in biofluids have emerged as potential biomarkers for disease.
Where most studies focus on blood-derived fluids, other biofluids may be more informative …

Impairment of the NKT–STAT1–CXCL9 axis contributes to vessel fibrosis in pulmonary hypertension caused by lung fibrosis

K Jandl, LM Marsh, AC Mutgan, S Crnkovic… - American Journal of …, 2022 - atsjournals.org
Rationale: Pulmonary hypertension (PH) is a common, severe comorbidity in interstitial lung
diseases such as pulmonary fibrosis (PF), and it has limited treatment options. Excessive …

Pulmonary hypertension and right heart dysfunction in chronic lung disease

A Zangiabadi, CG De Pasquale… - BioMed research …, 2014 - Wiley Online Library
Group 3 pulmonary hypertension (PH) is a common complication of chronic lung disease
(CLD), including chronic obstructive pulmonary disease (COPD), interstitial lung disease …

Pulmonary vascular fibrosis in pulmonary hypertension–The role of the extracellular matrix as a therapeutic target

K Jandl, N Radic, K Zeder, G Kovacs… - Pharmacology & …, 2023 - Elsevier
Pulmonary hypertension (PH) is a condition characterized by changes in extracellular matrix
(ECM) deposition and vascular remodeling of distal pulmonary arteries. These changes …

Beneficial and detrimental role of adenosine signaling in diseases and therapy

H Liu, Y Xia - Journal of applied physiology, 2015 - journals.physiology.org
Adenosine is a major signaling nucleoside that orchestrates cellular and tissue adaptation
under energy depletion and ischemic/hypoxic conditions by activation of four G protein …